Information about Az.Pharmabel
My details
*
*
*

Az.Pharmabel (SPRL)

BE 0508.863.780

Rue Richard Vandevelde 57a, 1030 Schaerbeek

Company information

Status
Active

Enterprise number

BE0508.863.780

VAT liability
Yes
Established
27-12-2012
Last balance sheet year
2025
Company size
Micro 1 FTE
Principal activity
Retail sale of pharmaceutical products
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Az.Pharmabel

2025 2024 2023 2022
Profit/Loss € 8,418 -82 % € 46,416 349 % € 10,341 -47 % € 19,442
Turnover € 966,662 -2 % € 983,777 6 % € 928,446 2 % € 909,928
Equity € 100,741 9 % € 92,323 101 % € 45,907 29 % € 35,566
Gross margin € 69,439 -27 % € 95,362 21 % € 78,949 -18 % € 96,094
Employees 1 1

Publications from Az.Pharmabel

Date Publication
15-01-2013 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (FR)

Frequently asked questions

What is the VAT number of Az.Pharmabel?
The VAT number of Az.Pharmabel is BE 0508.863.780.
Wat is the PEPPOL ID of Az.Pharmabel?
The PEPPOL ID of Az.Pharmabel is 0208:0508863780. Log in or start a free trial to see the full overview.
When was Az.Pharmabel founded?
Az.Pharmabel was founded on 27-12-2012.
What is the address of Az.Pharmabel?
The current registered office of Az.Pharmabel is located at Rue Richard Vandevelde 57a, 1030 Schaerbeek.
When was the last time Az.Pharmabel filed their annual financial statements?
The most recent financial statements of Az.Pharmabel were filed on 25-02-2026.
How many employees does Az.Pharmabel have?
There are 1 FTEs working at Az.Pharmabel according to the staff figures in the most recent financial statements.
What is the annual turnover of Az.Pharmabel?
At the time of its most recent financial statements, Az.Pharmabel recorded a total turnover of €966,662.00.

Sources